Glaxosmithkline | Ventas



Sales Cambio Fecha
AbbVie USD 13.34B 1.76B 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.26B 300M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Indivior 266M 32M 2025-03
J&J USD 21.89B 630M 2025-03
Merck USD 15.53B 94M 2025-03
Novartis USD 13.15B 330M 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Pfizer USD 13.72B 4.04B 2025-03
Prestige Brands USD 290.32M 6.53M 2024-12
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Takeda JPY 1.14T 40B 2024-12
Teva Pharmaceutical Industries USD 15.33B 11B 2024-12
Zoetis USD 2.32B 71M 2024-12



Glaxosmithkline Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.